Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration

NCT07221656 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07221656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07221656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Not yet recruiting
Start date
February 1, 2027
Completion date
December 31, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood acute lymphoblastic leukemia, childhood lymphoblastic lymphoma